Biomatics Capital
Biomatics Capital is a venture capital firm focused on transforming the future of healthcare through strategic investments in genomics and digital data. The firm aims to develop superior therapeutics, diagnostics, and delivery models that lead to a value-based healthcare system with lower costs and better patient outcomes. Biomatics Capital partners with entrepreneurs to support groundbreaking technologies and create exceptional value through a network of experts.
Biomatics Capital
Portfolio
Thrive was acquired by Exact Sciences in a $2.15 billion deal, highlighting its significant impact in the liquid biopsy space.
#Healthcare
AiCure has been recognized for its advancements in artificial intelligence for patient monitoring and has raised $24.5 million in a Series C round.
#Healthcare Technology
Aledade has been recognized for its cost-saving successes and was named one of the 2020 Best Workplaces in Health Care & Biopharma by Great Place to Work® and Fortune.
#Healthcare
Twist Bioscience is known for its innovative DNA synthesis technology and has partnered with Vanderbilt University Medical Center to identify antibody therapeutics for COVID-19.
#Biotechnology
Verana Health has strengthened its leadership team and secured $30 million in financing led by GV.
#Healthcare Technology